Kevin is a Partner at Centri Business Consulting, where he leads the firm’s Artificial Intelligence and Cannabis practice groups. Since joining Centri in December 2014, Kevin has specialized in supporting high-growth companies, particularly those in the AI, technology and cannabis industries, through critical stages of their business lifecycle.

Kevin has extensive experience guiding companies through expansion stages, including subsequent rounds of financing, acquisitions, and capital markets transactions. His expertise encompasses initial public offerings (IPOs), acquisitions, and divestitures. He excels in leading complex transactions, such as debt and equity arrangements, acquisition accounting process integration, and due diligence. Kevin also provides IPO and M&A readiness services, ensuring clients are well-prepared for their financial reporting requirements. He assists with preparing periodic filings with the Securities and Exchange Commission (SEC), including S-1, S-4, 8-K, Proxy, 10-Q, 10-K, and Form 10 filings.

Before joining Centri, Kevin worked at Friedman LLP, where he handled private and public engagements across various industries, including life sciences, technology, real estate, entertainment, and financial services. During this time, he focused on emerging growth and publicly traded companies, guiding clients through the financial reporting process of going public via reverse mergers.

Kevin holds a B.S. in Accounting from Saint Joseph’s University. He is actively involved in the leadership committee of Project Magis and the Capital Markets Council of the American Trade Association for Cannabis and Hemp (ATACH). Additionally, Kevin is a member of both the American and Pennsylvania Institute of Certified Public Accountants (AICPA and PICPA).